EX-21.1 4 exhibit211-subsidiaries.htm EX-21.1 Document

Exhibit 21.1

Subsidiaries
Name of SubsidiaryJurisdiction of Incorporation or OrganizationPercentage of Ownership by the Registrant
BeiGene 101Cayman Islands100 %
BeiGene AUS Pty Ltd.Australia100 %
BeiGene (Beijing) Co., Ltd.People’s Republic of China100 %
BeiGene Biologics Co., Ltd.People’s Republic of China100 %
BeiGene (Canada) ULCCanada 100 %
BeiGene ESP, S.L.Spain100 %
BeiGene France SarlFrance100 %
BeiGene Germany GmbHGermany100 %
BeiGene Guangzhou Biologics Manufacturing Co., Ltd.People’s Republic of China100 %
BeiGene (Guangzhou) Co., Ltd.People’s Republic of China100 %
BeiGene (Hong Kong) Co., LimitedHong Kong100 %
Beijing Innerway Bio-tech Co., Ltd.People’s Republic of China100 %
BeiGene International GmbHSwitzerland100 %
BeiGene Ireland LimitedRepublic of Ireland100 %
BeiGene (Italy) SarlItaly100 %
BeiGene Japan, Ltd.Japan100 %
BeiGene Korea Y.H.South Korea100 %
BeiGene Netherlands B.VNetherlands100 %
BeiGene NZ, LimitedNew Zealand100 %
BeiGene Pharmaceuticals GmbHSwitzerland100 %
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd.People’s Republic of China100 %
BeiGene Pharmaceutical (Shanghai) Co., Ltd.People’s Republic of China100 %
BeiGene (Shanghai) Co., Ltd.People’s Republic of China100 %
BeiGene (Shanghai) Research & Development Co., Ltd.People’s Republic of China100 %
BeiGene Singapore Pte., Ltd.Singapore100 %
BeiGene (Suzhou) Co., Ltd.People’s Republic of China100 %
BeiGene Switzerland GmbHSwitzerland100 %
BeiGene (Taiwan) LimitedTaiwan100 %
BeiGene UK, Ltd.United Kingdom100 %
BeiGene United Kingdom, Ltd.United Kingdom100 %
BeiGene USA, Inc.Delaware, United States100 %
BeiGene US Holdings, LLCDelaware, United States100 %
BeiGene US Manufacturing Co., Inc.Delaware, United States100 %